{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:46:53Z","timestamp":1791100013711,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2010,5,26]],"date-time":"2010-05-26T00:00:00Z","timestamp":1274832000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1038\/ja.2010.50","type":"journal-article","created":{"date-parts":[[2010,7,27]],"date-time":"2010-07-27T07:07:40Z","timestamp":1280214460000},"page":"381-384","source":"Crossref","is-referenced-by-count":47,"title":["Promising lead compounds for novel antiprotozoals"],"prefix":"10.1038","volume":"63","author":[{"given":"Kazuhiko","family":"Otoguro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Iwatsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki","family":"Ishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Namatame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki","family":"Nishihara-Tukashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Shibahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"\u014cmura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,26]]},"reference":[{"key":"BFja201050_CR1","unstructured":"WHO. World Malaria Report 2009."},{"key":"BFja201050_CR2","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/ja.2010.32","volume":"63","author":"K Otoguro","year":"2010","unstructured":"Otoguro, K. et al. In vitro and in vivo antiprotozoal activities of bispolides and their derivatives. J. Antibiot. 63, 275\u2013277 (2010).","journal-title":"J. Antibiot."},{"key":"BFja201050_CR3","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/ja.2008.52","volume":"61","author":"K Otoguro","year":"2008","unstructured":"Otoguro, K. et al. Selective and potent in vitro antitrypanosomal activities of 10 microbial metabolites. J. Antibiot. 61, 372\u2013378 (2008).","journal-title":"J. Antibiot."},{"key":"BFja201050_CR4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/ja.2008.83","volume":"61","author":"A Ishiyama","year":"2008","unstructured":"Ishiyama, A. et al. In vitro and in vivo antitrypanosomal activities of two microbial metabolites, KS-505a and alazopeptin. J. Antibiot. 61, 627\u2013632 (2008).","journal-title":"J. Antibiot."},{"key":"BFja201050_CR5","doi-asserted-by":"publisher","first-page":"658","DOI":"10.7164\/antibiotics.54.658","volume":"54","author":"K Otoguro","year":"2001","unstructured":"Otoguro, K. et al. Potent antimalarial activities of the polyether antibiotic, X-206. J. Antibiot. 54, 658\u2013663 (2001).","journal-title":"J. Antibiot."},{"key":"BFja201050_CR6","doi-asserted-by":"publisher","first-page":"727","DOI":"10.7164\/antibiotics.56.727","volume":"56","author":"K Otoguro","year":"2003","unstructured":"Otoguro, K. et al. In vitro and in vivo antimalarial activities of a non-glycoside 18-membered macrolide antibiotic, borrelidin, against drug-resistant strains of Plasmodia. J. Antibiot. 56, 727\u2013729 (2003).","journal-title":"J. Antibiot."},{"key":"BFja201050_CR7","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/ja.2007.27","volume":"60","author":"H Ui","year":"2007","unstructured":"Ui, H. et al. Selective and potent in vitro antimalarial activities found in four microbial metabolites. J. Antibiot. 60, 220\u2013222 (2007).","journal-title":"J. Antibiot."},{"key":"BFja201050_CR8","doi-asserted-by":"publisher","first-page":"340","DOI":"10.7164\/antibiotics.30.340","volume":"30","author":"M Miyamoto","year":"1977","unstructured":"Miyamoto, M. et al. Structure and synthesis of neothramycin. J. Antibiot. 30, 340\u2013343 (1977).","journal-title":"J. Antibiot."},{"key":"BFja201050_CR9","doi-asserted-by":"publisher","first-page":"444","DOI":"10.7164\/antibiotics.21.444","volume":"21","author":"K Yagishita","year":"1968","unstructured":"Yagishita, K., Utahara, R., Maeda, K., Hamada, M. & Umezawa, H. Acrylamidine, an anti-fungal substance produced by a Streptomyces. J. Antibiot. 21, 444\u2013450 (1968).","journal-title":"J. Antibiot."},{"key":"BFja201050_CR10","first-page":"103","volume":"14","author":"S Nakamura","year":"1961","unstructured":"Nakamura, S., Karasawa, K., Yonehara, H., Tanaka, N. & Umezawa, H. A new antibiotic, amidinomycin. [N-(2\u2032-amidinoethyl)-3-aminocy-clopentanecarboxamide] produced by a Streptomyces. J. Antibiot. 14, 103\u2013106 (1961).","journal-title":"J. Antibiot."},{"key":"BFja201050_CR11","first-page":"163","volume":"14","author":"S Nakamura","year":"1961","unstructured":"Nakamura, S., Umezawa, H. & Ishida, N. Identity of amidinomycin with myxoviromycin. J. Antibiot. 14, 163\u2013164 (1961).","journal-title":"J. Antibiot."},{"key":"BFja201050_CR12","doi-asserted-by":"publisher","first-page":"476","DOI":"10.7164\/antibiotics.39.476","volume":"39","author":"Y Ikeda","year":"1986","unstructured":"Ikeda, Y. et al. D-\u03b2-Lysylmethanediamine, a new biogenetic amine produced by a Streptomyces. J. Antibiot. 39, 476\u2013478 (1986).","journal-title":"J. Antibiot."},{"key":"BFja201050_CR13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.7164\/antibiotics.21.307","volume":"21","author":"Y Ito","year":"1968","unstructured":"Ito, Y. et al. New basic water-soluble antibiotics BD-12 and BY-81. II. Isolation, purification and properties. J. Antibiot. 21, 307\u2013312 (1968).","journal-title":"J. Antibiot."},{"key":"BFja201050_CR14","doi-asserted-by":"publisher","first-page":"921","DOI":"10.7164\/antibiotics.34.921","volume":"34","author":"Y Kawakami","year":"1981","unstructured":"Kawakami, Y., Yamasaki, K. & Nakamura, S. The structures of component A1 (=LL-AB664) and component A2 (LL-AC541), streptothricin-like antibiotics. J. Antibiot. 34, 921\u2013922 (1981).","journal-title":"J. Antibiot."},{"key":"BFja201050_CR15","doi-asserted-by":"publisher","first-page":"636","DOI":"10.7164\/antibiotics.31.636","volume":"31","author":"I Haupt","year":"1978","unstructured":"Haupt, I., H\u00fbbener, R. & Thrum, H. Streptothricin F, an inhibitor of protein synthesis with miscoding activity. J. Antibiot. 31, 636\u2013642 (1978).","journal-title":"J. Antibiot."},{"key":"BFja201050_CR16","doi-asserted-by":"publisher","first-page":"607","DOI":"10.7164\/antibiotics.51.607","volume":"51","author":"M Hisamoto","year":"1998","unstructured":"Hisamoto, M. et al. A-53930A and B, novel N-type Ca2+ channel blockers. J. Antibiot. 51, 607\u2013617 (1998).","journal-title":"J. Antibiot."},{"key":"BFja201050_CR17","doi-asserted-by":"publisher","first-page":"902","DOI":"10.7164\/antibiotics.24.902","volume":"24","author":"S Takahashi","year":"1971","unstructured":"Takahashi, S. et al. A new antibiotic, cyclamidomycin. J. Antibiot. 24, 902\u2013903 (1971).","journal-title":"J. Antibiot."},{"key":"BFja201050_CR18","doi-asserted-by":"publisher","first-page":"974","DOI":"10.7164\/antibiotics.28.974","volume":"28","author":"T Saeki","year":"1975","unstructured":"Saeki, T., Hori, M. & Umezawa, H. Effect of desdanine on nucleoside diphosphate kinase and pyruvate kinase of Escherichia coli. J. Antibiot. 28, 974\u2013981 (1975).","journal-title":"J. Antibiot."},{"key":"BFja201050_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1139\/m72-040","volume":"18","author":"F Reusser","year":"1972","unstructured":"Reusser, F. Desdanine, an inhibitor of oxidative phosphorylation in mitochondria. Can. J. Microbiol. 18, 265\u2013269 (1972).","journal-title":"Can. J. Microbiol."},{"key":"BFja201050_CR20","first-page":"191","volume":"1961","author":"AD Argoudelis","year":"1962","unstructured":"Argoudelis, A. D., Jahnke, H. K. & Fox, J. A. Pactamycin, a new antitumor antibiotic. II. Isolation and characterization. Antimicrob. Agents Chemother. 1961, 191\u2013197 (1962).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja201050_CR21","first-page":"230","volume":"17","author":"S Kondo","year":"1964","unstructured":"Kondo, S., Shimura, M., Sezaki, M., Sat\u014d, K. & Hara, T. Isolation and characterization of cranomycin, a new antibiotic. J. Antibiot. Ser. A 17, 230\u2013233 (1964).","journal-title":"J. Antibiot. Ser. A"},{"key":"BFja201050_CR22","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S0092-8674(00)00216-6","volume":"103","author":"DE Brodersen","year":"2000","unstructured":"Brodersen, D. E. et al. The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30s ribosomal subunit. Cell 103, 1143\u20131154 (2000).","journal-title":"Cell"},{"key":"BFja201050_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.7164\/antibiotics.29.93","volume":"29","author":"T Takeuchi","year":"1976","unstructured":"Takeuchi, T. et al. Neothramycins A and B, new antitumor antibiotics. J. Antibiot. 29, 93\u201396 (1976).","journal-title":"J. Antibiot."},{"key":"BFja201050_CR24","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7164\/antibiotics.31.761","volume":"31","author":"IN Maruyama","year":"1978","unstructured":"Maruyama, I. N., Suzuki, H. & Tanaka, N. Mechanism of action of neothramycin. I. The effect on macromolecular syntheses. J. Antibiot. 31, 761\u2013768 (1978).","journal-title":"J. Antibiot."},{"key":"BFja201050_CR25","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.pt.2003.09.002","volume":"19","author":"AH Fairlamb","year":"2003","unstructured":"Fairlamb, A. H. Chemotherapy of human African trypanosomiasis: current and future prospects. Trends Parasitol. 19, 488\u2013494 (2003).","journal-title":"Trends Parasitol."},{"key":"BFja201050_CR26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/00034983.1997.11813174","volume":"91","author":"RG Ridley","year":"1997","unstructured":"Ridley, R. G., Dom, A., Vippagunta, S. R. & Vennerstrom, J. L. Haematin (haem) polymerization and its inhibition by quinoline antimalarials. Ann. Trop. Med. Parasitol. 91, 559\u2013566 (1997).","journal-title":"Ann. Trop. Med. Parasitol."}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ja201050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ja201050","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ja201050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:16:07Z","timestamp":1684430167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ja201050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,26]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["BFja201050"],"URL":"https:\/\/doi.org\/10.1038\/ja.2010.50","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,26]]}}}